Search Results - Eric Mallack
- Showing 1 - 2 results of 2
-
1
Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trialResearch in context by Ángeles García-Cazorla, Caroline Sevin, Juliana Ribeiro Constante, Elise Yazbeck, Hendrik Rosewich, Sandra Jimenez, Gloria Chia-Yi Chiang, Otto Rapalino, Paul Caruso, Daniel Balentine, Karl G. Helmer, Seth Bennett, Marco Emanuele, Laura Rodriguez-Pascau, Pilar Pizcueta, Guillem Pina, Anna Vilà, Maria Rovira, Adriana Mantilla, Uwe Meya, Arun Mistry, María Pascual, Sílvia Pascual, Marc Martinell, Patricia L. Musolino, Eric Mallack
Published in EClinicalMedicine (2025-06-01)Get full text
Article -
2
Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophyResearch in context by Isabelle Weinhofer, Paulus Rommer, Andreas Gleiss, Markus Ponleitner, Bettina Zierfuss, Petra Waidhofer-Söllner, Stéphane Fourcade, Katharina Grabmeier-Pfistershammer, Marie-Christine Reinert, Jens Göpfert, Anne Heine, Hemmo A.F. Yska, Carlos Casasnovas, Verónica Cantarín, Caroline G. Bergner, Eric Mallack, Sonja Forss-Petter, Patrick Aubourg, Annette Bley, Marc Engelen, Florian Eichler, Troy C. Lund, Aurora Pujol, Wolfgang Köhler, Jörn-Sven Kühl, Johannes Berger
Published in EBioMedicine (2023-10-01)Get full text
Article
